Mandate

Vinge advises Orkla in connection with the acquisition of Zeelandia AB

Vinge has advised Orkla in connection with Orkla Food Ingredients AS’s acquisition of Zeelandia AB from Koninklijke Zeelandiaa Groep B.V.

Orkla is a leading actor of trademark and concept solutions for trading in convenience goods and large-scale catering institutions within the Nordic Region, Baltic Region, Central Europe and India. In 2018, the group’s turnover was NOK 41 billion and had approximately 18 500 employees. Orkla Food Ingredients is the largest actor within the bakery ingredients industry in the Nordic Region, and distributes products to 21 countries in total. The primary product categories are yeast, butter, plant‑based products, marzipan and margarine. Zeelandia AB’s product portfolio includes ingredients for all types of bread, buns, cakes and pastries as well as separating agents, balancing oils and food fillers, and is a strategic acquisition in order to strengthen Orkla’s position on the Nordic market. Following the acquisition, Zeelandia AB will change its name to Credin Sverige AB.

The acquisition is conditional upon the consent of the relevant competition authorities and other customary closing conditions.

Vinge’s team consisted of partners Peter Sundgren and Johan Karlsson together with, among others, associates Filip Öhrner, Christina Odengran, Isabelle Jengsell, Christoffer Nordin, Karin Virding, Lisa Ullman and project assistant Viktoria Owetz. Trine Osen Bergquist and Sebastian Örndahl provided competition law advice.

Related

Vinge advises Meribel Pharma Solutions

Vinge advises Meribel Pharma Solutions in connection with the sale of their production facility in Uppsala to Ofichem. The Uppsala site specializes in small-scale, early-phase development work.
August 13, 2025

Vinge advises Isofol Medical AB (publ) in connection with its rights issue of units

Through the rights issue of units, consisting of shares and warrants, and the exercised over-allotment issue, Isofol will receive approximately SEK 84 million and may receive an additional maximum of approximately SEK 110 million upon exercise of all warrants at the highest subscription price.
August 01, 2025

Vinge advises Oncorena in connection with share issue

Vinge advises Oncorena Holding AB in connection with a share issue of approximately SEK 133 million.
July 30, 2025